Abstract:Toll-like receptor 3 (TLR3) is an important member of the innate immune response receptor toll-like receptors (TLRs) family, which plays a vital role in regulating immune response, promoting the maturation and differentiation of immune cells, and participating in the response of pro-inflammatory factors. TLR3 is activated by pathogen-associated molecular patterns and damage-associated molecular patterns, which support the pathophysiology of many diseases related to inflammation. An increasing number of studies have confirmed that TLR3, as a crucial medium of innate immunity, participates in the occurrence and development of cardiovascular diseases (CVDs) by regulating the transcription and translation of various cytokines, thus affecting the structure and physiological function of resident cells in the cardiovascular system, including vascular endothelial cells, vascular smooth muscle cells, cardiomyocytes, fibroblasts and macrophages. The dysfunction and structural damage of vascular endothelial cells and proliferation of vascular smooth muscle cells are the key factors in the occurrence of vascular diseases such as pulmonary arterial hypertension, atherosclerosis, myocardial hypertrophy, myocardial infarction, ischaemia/reperfusion injury, and heart failure. Meanwhile, cardiomyocytes, fibroblasts, and macrophages are involved in the development of CVDs. Therefore, the purpose of this review was to explore the latest research published on TLR3 in CVDs and discuss current understanding of potential mechanisms by which TLR3 contributes to CVDs. Even though TLR3 is a developing area, it has strong treatment potential as an immunomodulator and deserves further study for clinical translation.

Toll-like receptor 3 and its signaling pathway

Toll-like Receptor 3 and Tumor Immunity

Progress in innate immunity signaling molecule STING

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Toll-Like Receptor 3 in Liver Diseases

ZCCHC3 modulates TLR3-mediated signaling by promoting recruitment of TRIF to TLR3

Research Progress in Toll-like Receptor Signal Pathways

The toll-like receptor 3:dsRNA signaling complex.

Toll-Like Receptor 3 in Cardiovascular Diseases

[Progress on Mechanisms for Pathogensto Evade NOD-like Receptor and Toll-like Receptor Signaling Pathways].

Mechanisms and Regulations of TLRs-and RLRs-mediated Cellular Antiviral Signaling

Poly(Di Center Dot Dc)-Induced Toll-Like Receptor 3 (Tlr3)-Mediated Activation Of Nf Kappa B And Map Kinase Is Through An Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing The Signaling Components Tlr3-Traf6-Tak1-Tab2-Pkr

Poly(I-C)-induced Toll-like Receptor 3 (Tlr3)-Mediated Activation of NFκB and MAP Kinase is Through an Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR

The Roles of TRAF3 in Immune Responses.

Innate antiviral host defense attenuates TGF-β function through IRF3-mediated suppression of Smad signaling.

Toll-like Receptors in Innate Immunity and Infectious Diseases

MicroRNAs: New Regulators of Toll-Like Receptor Signalling Pathways

Progress of research on Toll like receptors and viral infection

Research progress about toll-like receptors signaling pathways and the regulation on inflammatory cytokines

The Functional Mechanisms of Toll-Like Receptor 3 and Its Implications in Digestive System Tumors.